Skip to main content
. 2015 Aug;7(8):1398–1405. doi: 10.3978/j.issn.2072-1439.2015.07.25

Table S2. The ROC curve analyze results of genes greatly elevated in LUSC.

Gene LUAD LUSC Fold-change (LUSC/LUAD) AUC value
DSG3 88±777 8,728±8,556 98.77 0.973
KRT5 1,227±10,342 116,689±96,742 95.03 0.972
DSC3 128±789 7,515±6,291 58.62 0.970
CALML3 141±1,096 10,039±11,031 71.17 0.964
SERPINB13 22±191 2,166±3,217 95.70 0.956
KRT6B 310±1,208 17,808±27,334 57.45 0.954
KRT6C 136±529 7,372±12,063 54.13 0.954
KRT6A 2,297±8,724 87,096±81,359 37.91 0.951
PVRL1 1,204±1,177 11,200±7,063 9.30 0.950
LOC642587 59±213 1,247±1,247 20.99 0.949
PERP 6,258±4,951 31,500±21,939 5.03 0.947
TP63 325±914 10,976±9,139 33.72 0.946
TRIM29 861±1,930 11,291±7,291 13.10 0.945
ATP1B3 1,866±1,138 9,231±6,592 4.94 0.945
FAT2 125±383 3,737±3,587 29.82 0.943
CLCA2 87±691 6,787±7,536 77.23 0.943
SPRR2A 43±546 4,036±8,211 93.51 0.940
JAG1 1,118±1,157 7,365±7,830 6.58 0.939
KRT14 315±3,191 26,428±57,383 83.77 0.939
SERPINB5 358±904 4,421±3,570 12.32 0.937
KRT13 225±2,423 18,866±41,338 83.76 0.934
CSTA 190±403 4,222±5,543 22.20 0.934
PKP1 882±2,176 19,788±16,151 22.42 0.934
DAPL1 15±102 1,098±1,932 69.02 0.933
IRF6 647±369 3,108±1,757 4.80 0.932
KRT16 310±1,070 17,386±35,463 56.03 0.932
SLC6A8 965±1,028 7,254±5,830 7.52 0.929
SPRR2E 13±179 1,158±3,196 84.41 0.929
A2ML1 106±1,345 1,717±3,166 16.10 0.929
GPC1 1,375±1,171 9,223±8,003 6.71 0.926
HR 60±115 1,104±1,530 18.30 0.923
KRT17 2,926±8,839 62,551±69,399 21.37 0.921
COL7A1 442±945 5,390±5,665 12.17 0.919
SLC2A1 4,007±4,652 23,021±18,217 5.74 0.918
ANXA8 240±740 3,194±3,237 13.30 0.916
PTHLH 149±307 3,642±5,287 24.41 0.914
GBP6 71±203 2,247±2,528 31.33 0.913
ABCC5 1,037±1,012 7,355±7,806 7.09 0.912
SPRR1A 36±250 2,333±4,852 63.44 0.912
SNAI2 255±444 1,149±731 4.49 0.911
SLC16A1 597±1,019 2,486±1,753 4.16 0.910
TFRC 3,415±3,639 18,175±19,185 5.32 0.910
FOXE1 80±276 1,593±1,939 19.72 0.908
BMP7 172±530 1,843±1,470 10.70 0.907
ITGA6 1,937±3,063 8,650±7,228 4.46 0.906
NTRK2 173±794 7,764±9,701 44.79 0.905
ST6GALNAC2 287±316 1,438±978 5.00 0.904
CELSR2 487±386 2,204±1,814 4.53 0.904
ODZ2 29±146 1,147±1,729 38.99 0.904
ADAM23 26±90 1,535±2,091 57.10 0.902
GJB6 96±265 2,657±4,069 27.65 0.899
ANXA8L2 133±347 1,201±1,194 8.99 0.897
LGALS7 33±147 1,397±3,297 41.66 0.897
S100A7 79±824 2,320±11,972 29.29 0.896
RHCG 62±554 2,294±5,834 36.71 0.894
NRARP 217±196 1,068±1,082 4.92 0.894
S100A2 1,037±4,073 14,533±20,550 14.01 0.890
ADH7 71±513 2,704±3,930 37.83 0.887
LYPD3 428±839 3,478±4,530 8.12 0.886
SPRR3 75±497 4,179±9,702 55.54 0.884
COL4A5 312±414 1,956±2,391 6.26 0.884
CXCR7 609±1,045 4,107±4,471 6.74 0.883
C3orf58 458±333 1,881±1,718 4.10 0.883
PTPRZ1 222±538 2,422±2,239 10.88 0.882
GPR87 239±399 1,358±1,159 5.68 0.881
RAPGEFL1 302±456 1,882±1,782 6.22 0.880
UGT1A7 8±77 1,054±2,247 128.92 0.880
SPRR2D 87±428 2,165±4,477 24.63 0.878
SPRR1B 178±777 3,747±6,231 20.96 0.878
KRT15 1,280±4,508 20,918±28,994 16.33 0.878
PI3 352±4431 5,523±12,731 15.67 0.876
SFN 3,844±3,146 17,013±14,551 4.43 0.876
FABP5 157±305 1,443±2,707 9.15 0.876
RBP1 360±732 2,217±3,706 6.15 0.873
DST 2,550±2,332 10,378±8,529 4.07 0.873
PITX1 329±586 2,003±2,523 6.08 0.870
FAM84A 302±428 1,341±1,198 4.44 0.865
UPK1B 266±1,452 2,995±5,424 11.24 0.864
ADM 503±728 2,123±2,249 4.22 0.862
SOX2 479±830 43,21±4,483 9.02 0.862
CLDN1 2,085±3,554 15,300±19,672 7.34 0.861
MAGEA4 323±2,589 2,327±4,114 7.19 0.860
NDUFA4L2 632±1,412 4,587±5,094 7.25 0.860
SERPINB4 78±380 1,223±3,002 15.63 0.853
FGFBP1 236±491 2,053±2,791 8.70 0.851
SERPINB3 344±1,591 3,359±6,296 9.75 0.848
NTS 1,909±15,405 8,452±21,005 4.43 0.846
FGFR2 547±653 2,244±2,092 4.10 0.845
RGMA 233±383 1,250±1,463 5.35 0.841
ALDH3B2 288±450 1,176±1,362 4.08 0.838
CYP2S1 568±775 3,034±2,938 5.33 0.833
GPNMB 6,752±7,084 30,334±47,047 4.49 0.831
NDRG4 172±226 1,102±1,372 6.39 0.825
GJB2 862±1,422 6,171±10,796 7.15 0.820
ABCA13 257±471 1,296±1,327 5.04 0.812
FBN2 154±1,446 1,750±3,324 11.34 0.812
CRYAB 187±291 1,272±4,611 6.80 0.811
MMP10 194±1,193 3,002±7,273 15.47 0.808
NRCAM 221±609 1,241±1,578 5.61 0.806
HAS3 1,028±1,839 4,158±4,225 4.04 0.804
IL1RN 449±537 2,017±2,468 4.49 0.804
S100A8 1,344±8,937 1,1440±28,668 8.51 0.802
CNTNAP2 164±561 1,116±1,722 6.78 0.798
COL17A1 1,339±3,023 6,832±10,661 5.10 0.797
AKR1B10 2,145±7,972 9,111±13,901 4.25 0.794
WNT5A 633±563 2,606±2,816 4.12 0.789
CYP4F3 141±485 1,153±1,964 8.14 0.773
LY6D 214±729 3,033±6,896 14.13 0.765
ALDH3A1 1,848±7,693 8,124±17,776 4.40 0.759
IVL 207±501 1,093±2,097 5.26 0.758
CYP4F11 271±579 2,195±3,752 8.09 0.725
GSTM2 458±496 2,044±3,044 4.46 0.703
GSTM3 609±941 2,866±4,641 4.70 0.696
GPC3 540±1,255 2,291±3,642 4.24 0.684
KRT4 228±1,156 2,160±9,487 9.45 0.644
OLFM1 248±296 1,325±2,310 5.33 0.642
GSTM1 257±559 1,626±4,391 6.32 0.557
C4orf7 87±314 1,896±12,269 21.63 0.530

ROC, receiver operating characteristic; LUSC: lung squamous cell carcinoma; LUAD, lung adenocarcinoma; AUC: area under curve.